« Back
Home /
CRANAD-2

CRANAD-2

Item no.	HY-103242-1mg
Manufacturer	MedChem Express
Amount	1 mg
Quantity options	100 mg 10 mg 1 ea 1 mg 25 mg 5 mg
Specific against	other
Purity	98.0
Citations	[1]Ran C, et al. Design, synthesis, and testing of difluoroboron-derivatized curcumins as near-infrared probes for in vivo detection of amyloid-beta deposits. J Am Chem Soc. 2009 Oct 28;131(42):15257-61. [2]Ran C, et al. Non-conjugated small molecule FRET for differentiating monomers from higher molecular weight amyloid beta species. PLoS One. 2011 Apr 29;6(4):e19362.
Smiles	CN(C)C(C=C1)=CC=C1/C=C/C2=O[B+3]([F-])([F-])O=C(/C=C/C3=CC=C(N(C)C)C=C3)[CH-]2
Available
Product Description	CRANAD-2 is a near-infrared (NIR) Aβ plaque-specific fluorescent probe. CRANAD 2 penetrates the blood brain barrier and has a high affinity for Aβ aggregates with a Kd of 38 nM[1][2].
StorageTemperature	4°C (Powder, protect from light)
Shipping	Room Temperature
Applications	Neuroscience-Neurodegeneration
Molecular Weight	410.26
Clinical Information	No Development Reported
Manufacturer - Research Area	Neurological Disease
Solubility	DMSO : 2.08 mg/mL (ultrasonic; warming; heat to 60°C)
Target	Amyloid-β
Pathway	Neuronal Signaling
Manufacturer - Category	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-103242-1mg-safety-datasheet.pdf